Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Endo Health Solutions Inc    ENDP   US29264F2056

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

05/09/2012 | 02:44pm US/Eastern

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
React to this article
Latest news on ENDO HEALTH SOLUTIONS INC
05/18DJDow, S&P 500 Close at New Records
05/18DJMARKET SNAPSHOT : S&P 500, Dow Close At All-time Highs
05/18 WALL STREET STOCK EXCHANGE : Dow, S&P close at record highs as rate-hike angst a..
05/18DJStocks Gain; Dow, S&P 500 Flirt With Records
05/18 Endo pushes further into generics with $8 billion Par Pharma buy
05/18DJStocks Gain; Dow, S&P 500 Flirt With Records
05/18DJMARKET SNAPSHOT : S&P 500, Dow Climb To Fresh Records
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th Update
05/18DJU.S. Stocks Waver After Dow Touches Record
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd Update
Advertisement
Income Statement Evolution
More Financials